Your browser doesn't support javascript.
loading
Medicare Part D Coverage of Drugs Selected for the Drug Price Negotiation Program.
Patterson, Julie A; Wagner, Tyler D; O'Brien, John M; Campbell, Jonathan D.
Afiliação
  • Patterson JA; National Pharmaceutical Council, Washington, DC.
  • Wagner TD; National Pharmaceutical Council, Washington, DC.
  • O'Brien JM; National Pharmaceutical Council, Washington, DC.
  • Campbell JD; National Pharmaceutical Council, Washington, DC.
JAMA Health Forum ; 5(2): e235237, 2024 Feb 02.
Article em En | MEDLINE | ID: mdl-38334994
This cross-sectional study describes and historically benchmarks Medicare Part D coverage in 2019 and 2023 for the first 10 drugs selected for negotiation.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Medicare Part D / Medicamentos sob Prescrição Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Medicare Part D / Medicamentos sob Prescrição Idioma: En Ano de publicação: 2024 Tipo de documento: Article